Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

EMA Updates Guideline for Anticancer Medicines

January 14, 2013

ePT--the Electronic Newsletter of Pharmaceutical Technology

The European Medicines Agency has revised its guideline for the evaluation of anticancer medicinal products.

AbbVie Celebrates Official Launch

January 7, 2013

ePT--the Electronic Newsletter of Pharmaceutical Technology

AbbVie, a research-focused, specialty biopharmaceutical company that was spun off from Abbott Pharmaceuticals, was officially launched on Jan. 2, 2013

FDA Approvals of NMEs and BLAs Increased in 2012

January 2, 2013

ePT--the Electronic Newsletter of Pharmaceutical Technology

Additional approvals in December have helped to outpace a recent high set in 2011.

EMA and FDA on Process Validation

January 1, 2013
Pharmaceutical Technology

Siegfried Schmitt, a principal consultant with PAREXEL, discusses the EMA's guideline on process validation and how it compares with FDA's process validaton guidance.

Mylan Recalls Painkiller Pills due to Risk of Higher Dosage

December 24, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Mylan issued a voluntary recall of three lots of the painkiller tablets hydrocodone bitartrate and acetaminophen.

GSK Partners with Vodafone for Vaccinations

December 24, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

GlaxoSmithKline has formed a partnership with Vodafone to use mobile technology to help vaccinate more children against common infectious diseases in Africa.

BASF Extends Offer Period to Acquire Pronova BioPharma

December 19, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

BASF extended its offer period to acquire Pronova BioPharma, a producer of omega-3 fatty acids.

Ranbaxy Issues Voluntary Recall of Atorvastatin Due to Quality Issues

December 4, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

The company issues voluntary recall of certain lots due to possible contamination with small glass particles.

US Supreme Court to Hear Myriad Genetics' Gene Patentability Case

December 4, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Myriad Genetics reports that the US Supreme Court has granted certiorari agreeing to hear the company's gene patentability case.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here